| John D Cochran, MD | |
|
3949 S Cobb Dr Se, Smyrna, GA 30080-6342 | |
| (770) 438-5215 | |
| Not Available |
| Full Name | John D Cochran |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 3949 S Cobb Dr Se, Smyrna, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013951565 | NPI | - | NPPES |
| 197470 | Other | GA | BLUE SHIELD |
| 000862661H | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 042030 (Georgia) | Primary |
| Entity Name | Chestatee Pathology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568403988 PECOS PAC ID: 0840260097 Enrollment ID: O20040727000753 |
News Archive
Apixio Inc., the leading provider of clinical integration and medically intelligent search solutions for private health data, announced that its Community Search product has been tested and approved by Allscripts and is now featured in the Allscripts Application Store and Exchange on the company's ClientConnect website. Apixio is available today for users of Sunrise Clinical Manager (SCM) 5.5.
Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.
A new study examines the in vitro antiviral effect of pure budesonide and Pulmicort® against the SARS-CoV-2 WT and two VoCs.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
› Verified 8 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Apixio Inc., the leading provider of clinical integration and medically intelligent search solutions for private health data, announced that its Community Search product has been tested and approved by Allscripts and is now featured in the Allscripts Application Store and Exchange on the company's ClientConnect website. Apixio is available today for users of Sunrise Clinical Manager (SCM) 5.5.
Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.
A new study examines the in vitro antiviral effect of pure budesonide and Pulmicort® against the SARS-CoV-2 WT and two VoCs.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John D Cochran, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | John D Cochran, MD 3949 S Cobb Dr Se, Smyrna, GA 30080-6342 Ph: (770) 438-5215 |
News Archive
Apixio Inc., the leading provider of clinical integration and medically intelligent search solutions for private health data, announced that its Community Search product has been tested and approved by Allscripts and is now featured in the Allscripts Application Store and Exchange on the company's ClientConnect website. Apixio is available today for users of Sunrise Clinical Manager (SCM) 5.5.
Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.
A new study examines the in vitro antiviral effect of pure budesonide and Pulmicort® against the SARS-CoV-2 WT and two VoCs.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
› Verified 8 days ago
Gerson Paull, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3949 South Cobb Dr, Smyrna, GA 30080 Phone: 770-438-5215 | |
Dr. Charay Jennings-dover, M.D., PH.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 Lake Park Dr Se, Smyrna, GA 30080 Phone: 678-556-9411 | |
Wael H Milyani, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 Lake Park Dr Se, Smyrna, GA 30080 Phone: 706-737-4575 Fax: 706-731-5289 | |
Dr. Kristopher Michael Mckay, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2000 Lake Park Dr Se, Smyrna, GA 30080 Phone: 678-556-9411 Fax: 678-556-9413 | |
Andrea L Volk, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 2000 Lake Park Dr Se, Smyrna, GA 30080 Phone: 470-695-3453 | |
Dr. Abha Soni, D.O. Pathology Medicare: Medicare Enrolled Practice Location: 2000 Lake Park Dr Se, Smyrna, GA 30080 Phone: 678-556-9411 Fax: 678-556-9413 |